The REACH project aims to develop novel technology for the production of cell-based therapeutic products. Widespread availability of cell therapy products (CTPs) is hindered by its production process. Xpand Biotechnology BV, together with PreSens Precision Sensing GmbH, Aber Instruments Ltd and Leiden University Medical Centre, will develop an innovative bioreactor system for the CTP industry.
Learn more
New video shows the power of the Scinus Cell Expansion system
REACH is developing for cell therapy
